Keyphrases
Kidney Transplant Recipients
49%
Kidney Transplantation
47%
Kidney
36%
Renal Transplant
29%
Kidney Transplant
28%
Immune Response
21%
Transplantation
21%
Self-antigens
20%
Transplant Recipients
18%
Single Center
17%
Acute Rejection
16%
Simultaneous Pancreas-kidney Transplant
13%
Confidence Interval
12%
Human Leukocyte Antigen
12%
Tacrolimus
12%
Adult Kidney
12%
Transplant Population
12%
Renal Transplantation
12%
Allograft
12%
Solid Organ Transplant Recipients
11%
Retrospective Cohort Study
10%
End-stage Renal Disease
10%
Cystinosis
9%
Cropping Pattern
9%
Small Farm Reservoir
9%
Rainfed Lowland
9%
Heavy Proteinuria
9%
Calcineurin Inhibitor Withdrawal
9%
Prolonged-release Tacrolimus
9%
Eculizumab
9%
Cytomegalovirus
9%
Focal Segmental Glomerulosclerosis
9%
Thrombotic Microangiopathy
9%
Reductase Inhibitors
9%
3-hydroxy-3-methylglutaryl-CoA Reductase
9%
Rituximab
9%
Editorial Team
9%
Organ Allocation
9%
Older Adults
9%
Treatment Refractory
9%
Quiescence
9%
HLA Matching
9%
Sitagliptin
9%
Allosensitization
9%
Immune Quiescence
9%
Hyperparathyroidism
9%
Randomized Double-blind Controlled Trial
9%
Chronic Kidney Disease Patients
9%
Obesity
9%
Adult Kidney Transplant Recipients
9%
Medicine and Dentistry
Kidney Graft
100%
Kidney Transplantation
44%
Tacrolimus
22%
Allograft
18%
Graft Failure
16%
End Stage Renal Disease
15%
Acute Kidney Injury
13%
Retrospective Study
12%
Cytomegalovirus
11%
Calcineurin Inhibitor
11%
Immunosuppressant
10%
Retrospective Cohort Study
10%
Cystinosis
9%
Proteinuria
9%
Chimeric Antigen Receptor T-Cell Immunotherapy
9%
Organ Transplantation
9%
Focal Segmental Glomerulosclerosis
9%
Posttransplant Lymphoproliferative Disease
9%
Diabetes Mellitus
9%
Prospective Study
9%
Antivirus Agent
9%
Haplotype
9%
Placebo
9%
Cardiovascular Risk
9%
Sitagliptin
9%
Hemodialysis
9%
Rituximab
9%
Hyperparathyroidism
9%
Kidney Pancreas Transplantation
9%
Eculizumab
9%
Glomerulonephritis
9%
Single Drug Dose
9%
Graft Versus Host Reaction
9%
Myocardial Disease
9%
Thrombotic Thrombocytopenic Purpura
9%
Bone Disease
9%
Bacterial Infection
9%
Iron
9%
Body Mass Index
9%
Cardiovascular System
9%
Immunosuppressive Treatment
8%
Chronic Kidney Disease
8%
Acute Graft Rejection
6%
Oral Glucose Tolerance Test
6%
Arm
6%
Solid Organ Transplantation
6%
Thymocyte Antibody
6%
Diseases
6%
Renal Replacement Therapy
5%
Viremia
5%